Fresenius SE & Co KGaA (FREG.DE)
14 Dec 2017
Tue, Nov 21 2017
FRANKFURT, Nov 21 German healthcare group Fresenius SE is well on its way to further increase its annual dividend next year, reflecting the prospect of earnings growth in 2017, its chief executive said.
The U.S. Justice Department is urging a federal judge not to dismiss some of its claims that kidney dialysis services company Fresenius SE & Co KGaA billed Medicare for medically unnecessary tests.
Fresenius SE & Co KGaA has secured an order to unseal portions of court documents filed by the U.S. Justice Department relating to its investigation of a whistleblower complaint accusing the kidney dialysis services company of billing for medically unnecessary services.
TEL AVIV, Oct 3 New York-based Senvest Management is shorting three drug stocks, Insys Therapeutics Inc , Akorn Inc and Fresenius SE, its chief executive Richard Mashaal said on Tuesday,
* Credit agreement has volume of around 3.8 billion euros, consists of revolving facilities and term loans with maturities in 2021 and 2022
FRANKFURT, Aug 1 Diversified German healthcare group Fresenius, controlled by a charitable trust, saw adjusted net income jump 21 percent, bolstered by new drug launches at its U.S. generic infusion division Kabi and by newly-acquired Quironsalud, Spain's largest hospital chain.
BERLIN, July 21 Fresenius named Rachel Empey as its chief financial officer on Friday, poaching her from Telefonica Deutschland.
* At yesterday's special meeting, shareholders of Akorn, Inc., have approved merger agreement with fresenius kabi, with 83.9 percent of outstanding shares being voted in favour of transaction. Source text for Eikon: Further company coverage:
* Akorn shareholders vote to approve merger agreement with Fresenius Kabi
* ABOUT 80 NEW JOBS ARE BEING CREATED AT THE SANTIAGO DE BESTEIROS PLANT BY THE EXPANSION Source text: http://bit.ly/2tUfsVP Further company coverage: (Gdynia Newsroom)